Gout Therapeutic Market to Reach US$3820 Million by 2027

1
Gout Therapeutic Market
Gout Therapeutic Market Segmentation by Drug
Type - Colchicine, Antihyperuricemic Agents,
Non-steroidal Anti-inflammatory Drugs,
Corticosteroids, Biologic Response Modifiers
Distribution Channel - Hospital Pharmacy, Retail
Pharmacy, Online Pharmacy, and Forecast, 2019 -
2027
2019 Transparency Market Research, All Rights
Reserved
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Acronyms
Chapter 3 Research Methodology
Chapter 4 Executive Summary Gout Therapeutic Market
Chapter 5 Market Overview
Chapter 6 Market Dynamics
Chapter 7 Global Gout Therapeutics Market Analysis and Forecast, by Component
Chapter 8 Global Gout Therapeutics Market Analysis and Forecast, by Distribution Channel
Chapter 9 Global Gout Therapeutics Market Analysis and Forecast, by Region
Chapter 10 North America Gout Therapeutics Market Analysis and Forecast
Chapter 11 Europe Gout Therapeutics Market Analysis and Forecast
Chapter 12 Asia Pacific Gout Therapeutics Market Analysis and Forecast
Chapter 13 Latin America Gout Therapeutics Market Analysis and Forecast
Chapter 14 Middle East Africa Gout Therapeutics Market Analysis and Forecast
Chapter 15 Competition Landscape
2019 Transparency Market Research, All Rights
Reserved
3

Gout Therapeutic Market - Snapshot

• Gout is a type of inflammatory arthritis caused
  by small crystals of a chemical called uric acid
  that form in the joints.
• Gout has both active and inactive periods. Active
  periods of gout are known as attacks and can
  vary in severity and length.
• Rise in prevalence of gout arthritis across the
  globe is anticipated to boost the global gout
  therapeutics market during the forecast period.

2019 Transparency Market Research, All Rights
Reserved
4
(No Transcript)
5
Reports Highlights

• The global gout therapeutics market is projected
  to reach US 3820 Mn by 2027, expanding at a CAGR
  of 8.3 from 2019 to 2027.
• Promising drug pipeline and approvals to propel
  gout therapeutics market.
• Increase in patient preference for biologics
  drives the demand for gout therapeutics.
• Antihyperuricemic agents (urate-lowering drugs)
  to be highly attractive segment.

Request For Sample
2019 Transparency Market Research, All Rights
Reserved
6
Continue..

• New product development and strategic alliances
  in international market.
• Key trend among leading players - Takeda
  Pharmaceutical Company Limited, Teijin Pharma
  Limited., Novartis AG, Mylan N.V., and Horizon
  Pharma plc.
• Asia Pacific to Exhibit Positive Growth Rate in
  Coming Years.
• Product Development and Strategic Alliances are
  Key for Leading Market Players include names such
  as MERCK Co. Inc., Iroko Pharmaceutical LLC,
  Hikma Pharmaceuticals PLC

Request For Brochure
2019 Transparency Market Research, All Rights
Reserved
7
Contact
To know more about us, please visit our website
www.transparencymarketresearch.com For sales
queries or new topics email us on
sales_at_transparencymarketresearch.com
Thank You
2019 Transparency Market Research, All Rights
Reserved